Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,352 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Activation of NADPH oxidase in Alzheimer's disease brains.
Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura A, Chiba S, Perry G, Smith MA, Fujimoto S. Shimohama S, et al. Among authors: Chiba S. Biochem Biophys Res Commun. 2000 Jun 24;273(1):5-9. doi: 10.1006/bbrc.2000.2897. Biochem Biophys Res Commun. 2000. PMID: 10873554
The present study is the first to show that superoxide (O(-)(2)) forming NADPH oxidase is activated in Alzheimer's disease (AD) brains by demonstrating the marked translocation of the cytosolic factors p47-phox and p67-phox to the membrane. ...
The present study is the first to show that superoxide (O(-)(2)) forming NADPH oxidase is activated in Alzheimer's disease (AD) brain …
Stabilization of urinary erythropoietin.
Chiba S, Kung CK, Goldwasser E. Chiba S, et al. Biochem Biophys Res Commun. 1972 Jun 28;47(6):1372-7. doi: 10.1016/0006-291x(72)90224-0. Biochem Biophys Res Commun. 1972. PMID: 5040238 No abstract available.
Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status.
Shrestha R, Sakata-Yanagimoto M, Maie K, Oshima M, Ishihara M, Suehara Y, Fukumoto K, Nakajima-Takagi Y, Matsui H, Kato T, Muto H, Sakamoto T, Kusakabe M, Nannya Y, Makishima H, Ueno H, Saiki R, Ogawa S, Chiba K, Shiraishi Y, Miyano S, Mouly E, Bernard OA, Inaba T, Koseki H, Iwama A, Chiba S. Shrestha R, et al. Among authors: Chiba K, Chiba S. Blood Adv. 2020 Mar 10;4(5):845-854. doi: 10.1182/bloodadvances.2019001324. Blood Adv. 2020. PMID: 32126143 Free PMC article.
MM2 cortical form of sporadic Creutzfeldt-Jakob disease without progressive dementia and akinetic mutism: A case deviating from current diagnostic criteria.
Takahashi-Iwata I, Yabe I, Kudo A, Eguchi K, Wakita M, Shirai S, Matsushima M, Toyoshima T, Chiba S, Tanikawa S, Tanaka S, Satoh K, Kitamoto T, Sasaki H. Takahashi-Iwata I, et al. Among authors: Chiba S. J Neurol Sci. 2020 Feb 24;412:116759. doi: 10.1016/j.jns.2020.116759. Online ahead of print. J Neurol Sci. 2020. PMID: 32114028 No abstract available.
Dasatinib is an effective treatment for angioimmunoblastic T-cell lymphoma.
Nguyen TB, Sakata-Yanagimoto M, Fujisawa M, Tanzima Nuhat S, Miyoshi H, Nannya Y, Hashimoto K, Fukumoto K, Bernard OA, Kiyoki Y, Ishitsuka K, Momose H, Sukegawa S, Shinagawa A, Suyama T, Sato Y, Nishikii H, Obara N, Kusakabe M, Yanagimoto S, Ogawa S, Ohshima K, Chiba S. Nguyen TB, et al. Among authors: Chiba S. Cancer Res. 2020 Feb 27:canres.2787.2019. doi: 10.1158/0008-5472.CAN-19-2787. Online ahead of print. Cancer Res. 2020. PMID: 32107212 Free article.
2,352 results
Jump to page
Feedback